Structure Therapeutics, Inc. (GPCR)
88.64
+3.62
(+4.26%)
USD |
NASDAQ |
Jan 16, 16:00
89.30
+0.66
(+0.74%)
After-Hours: 20:00
Structure Therapeutics Shareholders Equity (Quarterly): 770.02M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Novo Nordisk A/S | 26.74B |
| Pfizer Inc. | 92.80B |
| Viking Therapeutics, Inc. | 713.03M |
| Dyne Therapeutics, Inc. | 691.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 832.16M |
| Total Liabilities (Quarterly) | 62.14M |
| Debt to Equity Ratio | 0.0092 |
| Current Ratio | 14.15 |
| Net Debt Paydown Yield | -0.03% |